Merja
Soilu-Hänninen
Docent, Department of Clinical Medicine
MD, PhD
Contact
Links
Areas of expertise
Clinical neurology
neuroimmunology
multiple sclerosis risk factors, prognostic factors and treatment
Biography
MD, University of Turku 1988
PhD, University of Turku, Department of Virology, Immunobiology of central nervous system virus infections 1996
Postdoctoral Fellow, Development and Neurobiology Group, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia 1997-1999
Specialist Degree in Neurology 2001
Adjuct Professor of Clinical Neurology 2008
Inverstigator in several clinical MS trials
Chair of the Finnish MS registry 2016-
General Neurology Section Head, Turku University Hospital, Division of Clinical Neurosciences 2017-
Teaching
Course of medical pedagogics 2011-2012
Supervisor of several PhD student
Research
Multiple sclerosis risk factors, prognostic factors and epidemiology.
Imaging of brain atrophy in multiple sclerosis.
Publications
Patient Generated Digital Health Data: An Example from the Finnish Neuro Registry (2025)
International Conference on Informatics, Management, and Technology in Healthcare, Studies in Health Technology and Informatics
(A4 Vertaisarvioitu artikkeli konferenssijulkaisussa)
Evaluation of patient-perceived fatigue in multiple sclerosis utilizing the Finnish MS registry (2025)
Multiple Sclerosis Journal - Experimental, Translational and Clinical
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Finnish Registry-Based Protocol for Screening and Management of Fatigue and Cognitive Problems in Multiple Sclerosis: Observational Study (2025)
JMIR Human Factors
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Mortality and causes of death for people with multiple sclerosis: a Finnish nationwide register study (2025)
Journal of Neurology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria—a nationwide population-based registry study over five decades (2025)
Multiple Sclerosis Journal - Experimental, Translational and Clinical
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Evolving Patterns of Initial RRMS Treatment in Finland (2013–2022): Insights From a Nationwide Multiple Sclerosis Register (2025)
Brain and Behavior
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
The Real-World Efficacy of Cladribine Tablets and Treatment Persistence in People with Highly Active Relapsing Multiple Sclerosis in Finland – A Follow-up Study After Four Years of Observation (2025)
Multiple Sclerosis and Related Disorders
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Delays in treatment initiation for patients with relapsing-remitting multiple sclerosis—A nationwide population-based study (2025)
Multiple Sclerosis Journal - Experimental, Translational and Clinical
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )
Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION Study (2024)
Clinical Epidemiology
(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )